
### [NCIT:C135081](http://purl.obolibrary.org/obo/NCIT_C135081)
**Label:** Ampulla of Vater Neuroendocrine Tumor by AJCC v8 Stage

**Subclasses:** [NCIT:C135085](http://purl.obolibrary.org/obo/NCIT_C135085) (Stage IV Ampulla of Vater Neuroendocrine Tumor AJCC v8), [NCIT:C135084](http://purl.obolibrary.org/obo/NCIT_C135084) (Stage III Ampulla of Vater Neuroendocrine Tumor AJCC v8), [NCIT:C135083](http://purl.obolibrary.org/obo/NCIT_C135083) (Stage II Ampulla of Vater Neuroendocrine Tumor AJCC v8), [NCIT:C135082](http://purl.obolibrary.org/obo/NCIT_C135082) (Stage I Ampulla of Vater Neuroendocrine Tumor AJCC v8), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 53.12%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C32052](http://purl.obolibrary.org/obo/NCIT_C32052) (Alpha Cell))) 53.12%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36180](http://purl.obolibrary.org/obo/NCIT_C36180) (Multifocal Lesion))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36177](http://purl.obolibrary.org/obo/NCIT_C36177) (Single-File Linear Pattern))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36176](http://purl.obolibrary.org/obo/NCIT_C36176) (Bilateral Mass))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36163](http://purl.obolibrary.org/obo/NCIT_C36163) (Metastatic/Recurrent Disease))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36158](http://purl.obolibrary.org/obo/NCIT_C36158) (Chronic Clinical Course))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36157](http://purl.obolibrary.org/obo/NCIT_C36157) (Acute Clinical Course))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36155](http://purl.obolibrary.org/obo/NCIT_C36155) (Accelerated Phase of Disease))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36154](http://purl.obolibrary.org/obo/NCIT_C36154) (Chronic Phase of Disease))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36141](http://purl.obolibrary.org/obo/NCIT_C36141) (Intermediate Grade Lesion))) 38.48%
- [NCIT:C12573](http://purl.obolibrary.org/obo/NCIT_C12573) (Endocrine Cell of the Digestive System) and (not ([NCIT:C36140](http://purl.obolibrary.org/obo/NCIT_C36140) (Grade 4 Lesion))) 38.48%


